Zyprexa News

Lawsuit in the Works Over Zyprexa

- September 24, 2007

Eli Lily and Co., and other manufacturers of the diabetes medication, Zyprexa, have been accused of improperly marketing the drug.

Attorney General, Dustin McDaniel has informed state legislators that the suit will seek the money lost paid by the state's Medicaid program.

Medicaid reportedly lost money due to the fact that the anti-psychosis drugs that were mislabeled and prescribed for patients that shouldn't have been taking it.

McDaniel claims in the past eight years, Arkansas' Medicaid program spent about $200 million on prescriptions for Zyprexa, whose main manufacturer is Eli Lily and Co.

Other Companies Affected by the Suit

Many companies are being affected by the lawsuit filed seeking millions in retribution due to the medications risks and falsely marketing.

Aside from Lily, the Johnson & Johnson subsidiary Janssen Pharmaceutica and AstraZeneca are also targeted in the suit.

Reason for the Suit

According to McDaniel, Zyprexa has serious side effects that weren't exposed to consumers, including weight-gain and Type II diabetes.

“What the drug makers did was intentionally hide that and downplayed the efficiency of alternatives,” explained McDaniel.

McDaniel claims the companies engaged in a clever marketing scheme that catered the drug to patients whom the medication wasn't necessary for, such as the elderly and children.

It was reportedly marketed as a sort of “miracle drug” that was a fix for many unauthorized illnesses, however it ended up having very negative effects on these patients.

(Source: Forbes)

Have you or someone you know been harmed by Zyprexa? If so, please contact us to speak with an experienced attorney who will help you to seek legal compensation for your injuries.

Read More Zyprexa News....